Henrik Gronberg
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 236 publications
STHLM3 NorDCaP: prospective multicentre trial of Stockholm3 for active surveillance biopsy guidance.
STHLM3 NorDCaP: prospective multicentre trial of Stockholm3 for active surveillance biopsy guidance.
Journal: BJU international
Published: July 01, 2026
Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-up.
Journal: Annals of internal medicine
Published: June 22, 2026
Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate Cancer.
Journal: European urology focus
Published: April 02, 2026
Letter to the Editor: Advanced and Metastatic Prostate Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment, and Follow-up.
Journal: European urology
Published: February 20, 2026
Can Prostate Cancer Screening Reduce Mortality in Men Aged 75-79 Years? A Protocol for Target-trial Emulation.
Journal: European urology open science
Published: October 26, 2025
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.
Journal: European urology
Published: October 23, 2025
Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer.
Journal: The New England journal of medicine
Published: September 17, 2025
Time to BCR and cancer-specific mortality after radiotherapy or prostatectomy: implications for risk stratification and follow-up.
Journal: World journal of urology
Published: August 20, 2025
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial: Erratum.
Journal: The Journal of urology
Published: July 08, 2025
Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial.
Journal: European urology
Published: July 01, 2025
Detectable prostate-specific antigen after radiotherapy for clinically localized prostate cancer.
Journal: Cancer
Published: May 01, 2025
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial.
Journal: The Journal of urology
Published: April 09, 2025
Last Updated: 09/26/2026